Endometriosis: Advances and ControversiesTogas Tulandi, David Redwine CRC Press, 9 de dez. de 2003 - 360 páginas Addresses new concepts and theories in disease control and provides the latest treatment modalities. Dedicated to new developments in the medical and surgical treatment of endometriosis, this reference delves into current management controversies, examines emerging therapeutic strategies, and assists specialists in the design of new investigations and research paths for the study of this common condition. |
Conteúdo
1 Epidemiology of Endometriosis | 1 |
Peritoneal Endometriosis Ovarian Endometriosis and Rectovaginal Adenomyosis | 17 |
3 Anatomical Sites of Endometriosis | 40 |
4 Genetics of Endometriosis | 49 |
5 Research Aspects of Endometriosis | 61 |
6 Animal Models for Research on Endometriosis | 72 |
7 Immunology of Endometriosis and Immunotherapy | 88 |
8 Serum and Peritoneal Markers for Endometriosis | 109 |
An Overview | 149 |
11 Treatment with Aromatase Inhibitors | 168 |
Medical Treatment with Progestagens | 181 |
13 Gonadotropin Releasing Hormone Agonist and Antagonist for Endometriosis | 195 |
14 Management of Endometriosis After Hysterectomy and Bilateral SalpingoOophorectomy | 217 |
15 Treatment of Ovarian Endometrioma | 233 |
16 Treatment of EndometriosisRelated Pelvic Pain | 241 |
17 In Vitro Fertilization or Superovulation? Evidence Flaws and Advice | 260 |
9 How Does Endometriosis Cause Infertility? | 134 |
18 Does Endometriosis Affect the Results of In Vitro Fertilization? | 279 |
Outras edições - Ver todos
Termos e frases comuns
acetate activity adhesions antagonist appears aromatase associated baboons caused cells changes chronic Clin clinical compared concentrations controlled cycle cyst cytokines danazol decreased deep demonstrated diagnosis disease dose dysmenorrhea effect efficacy endometrial cells endometriosis-associated endometriotic implants estradiol estrogen eutopic evaluated evidence excision expression factor Fertil Steril findings gene GnRH agonist growth higher hormone Hum Reprod human immune implants important improvement increased induced infertility involvement laparoscopy lesions levels lower macrophages menstrual minimal months normal observed Obstet Gynecol oocyte oral ovarian ovary patients with endometriosis pelvic pain peritoneal fluid phase pregnancy prevalence production progesterone randomized rates recent receptor rectovaginal recurrence releasing reported reproductive response role secretion serum severe showed significant similar specificity stage stimulation stromal subfertility suggest suppression surgery surgical symptoms therapy tissue treated treatment of endometriosis trial uterine vitro women with endometriosis